Fondazione Ricerca Traslazionale   Report issue

Foundation Phase 2
Founded: Rome Italy

Organization Overview

First Clinical Trial
2014
NCT02499614
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Fondazione Ricerca Traslazionale